Literature DB >> 17383314

Actual management of patients with asymptomatic aortic valve disease: how practice fits with guidelines.

Bernard Iung1, David Messika-Zeitoun, Agnès Cachier, François Delahaye, Gabriel Baron, Pilar Tornos, Christa Gohlke-Bärwolf, Eric Boersma, Philippe Ravaud, Alec Vahanian.   

Abstract

BACKGROUND: Intervention is advised in selected asymptomatic patients with aortic valve disease. However, little is known regarding their actual management.
METHODS: The Euro Heart Survey was designed to evaluate practices. Severe isolated aortic stenosis (AS) was defined by a valve area < or = 0.6 cm2/m2 body surface area or mean gradient > or = 50 mm Hg. Severe aortic regurgitation (AR) was defined by a grade > or = 3/4. Patients were classified as asymptomatic when they were in New York Heart Association class I and were without angina. Decision to operate was analyzed by comparing patient characteristics with the American College of Cardiology/American Heart Association recommendations.
RESULTS: Of the 5001 patients, 136 had severe, isolated, and asymptomatic aortic valve disease (84 with AS and 52 with AR). Stress testing was performed in only 6 patients (4%). A decision to operate was taken in 45 patients (54%) with AS and 21 (40%) with AR. Indications for surgery were in accordance with the American College of Cardiology/American Heart Association guidelines in 57 patients (68%) with AS and in 41 (83%) with AR. However, the decision to operate was frequently based on class IIb recommendations in patients with AS. Intervention was "overused" in 18 patients with AS (21%) and in 5 (9%) with AR. Intervention was "underused" in 9 patients (11%) with AS and in 4 (8%) with AR.
CONCLUSIONS: In asymptomatic patients with severe aortic valve disease, a decision to operate is frequently taken; and it is most often in agreement with guidelines, although often based on low-level recommendations.

Entities:  

Mesh:

Year:  2007        PMID: 17383314     DOI: 10.1016/j.ahj.2005.12.031

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  4 in total

Review 1.  Patient screening for early detection of aortic stenosis (AS)-review of current practice and future perspectives.

Authors:  Martin Thoenes; Peter Bramlage; Pepe Zamorano; David Messika-Zeitoun; Daniel Wendt; Markus Kasel; Jana Kurucova; Richard P Steeds
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

2.  Quality of care assessment and improvement in aortic stenosis - rationale and design of a multicentre registry (IMPULSE).

Authors:  Norbert Frey; Richard P Steeds; Antonio Serra; Eberhard Schulz; Stephan Baldus; Matthias Lutz; Christiane Pohlmann; Jana Kurucova; Peter Bramlage; David Messika-Zeitoun
Journal:  BMC Cardiovasc Disord       Date:  2017-01-05       Impact factor: 2.298

3.  Caseload management and outcome of patients with aortic stenosis in primary/secondary versus tertiary care settings-design of the IMPULSE enhanced registry.

Authors:  Tanja K Rudolph; David Messika-Zeitoun; Norbert Frey; Matthias Lutz; Laura Krapf; Stephanie Passefort; John Fryearson; Helen Simpson; Kai Mortensen; Sebastian Rehse; Andreas Tiroke; Fotini Dodos; Florian Mies; Christiane Pohlmann; Jana Kurucova; Martin Thoenes; Peter Bramlage; Richard Paul Steeds
Journal:  Open Heart       Date:  2019-07-21

4.  Facilitated Data Relay and Effects on Treatment of Severe Aortic Stenosis in Europe.

Authors:  Richard P Steeds; Matthias Lutz; Jeetendra Thambyrajah; Antonio Serra; Eberhard Schulz; Jiri Maly; Marco Aiello; Tanja K Rudolph; Guy Lloyd; Alessandro Santo Bortone; Karl Eugen Hauptmann; Alberto Clerici; Georg Delle-Karth; Johannes Rieber; Ciro Indolfi; Massimo Mancone; Loic Belle; Alexander Lauten; Martin Arnold; Berto J Bouma; Cornelia Deutsch; Jana Kurucova; Martin Thoenes; Peter Bramlage; Norbert Frey; David Messika-Zeitoun
Journal:  J Am Heart Assoc       Date:  2019-09-24       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.